RGGYX
Price
$22.93
Change
+$0.41 (+1.82%)
Updated
Apr 24 closing price
Net Assets
1.25B
RWIHX
Price
$62.98
Change
+$0.99 (+1.60%)
Updated
Apr 24 closing price
Net Assets
119.48B
Ad is loading...

RGGYX vs RWIHX

Header iconRGGYX vs RWIHX Comparison
Open Charts RGGYX vs RWIHXBanner chart's image
Victory RS Global Y
Price$22.93
Change+$0.41 (+1.82%)
VolumeN/A
Net Assets1.25B
American Funds Capital World Gr&Inc R5E
Price$62.98
Change+$0.99 (+1.60%)
VolumeN/A
Net Assets119.48B
RGGYX vs RWIHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGGYX vs. RWIHX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGGYX is a Buy and RWIHX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWIHX has more cash in the bank: 119B vs. RGGYX (1.25B). RWIHX pays higher dividends than RGGYX: RWIHX (1.84) vs RGGYX (1.22). RGGYX was incepted earlier than RWIHX: RGGYX (14 years) vs RWIHX (9 years). RGGYX (0.84) is less costly to investors than RWIHX (0.56). RGGYX is a more actively managed with annual turnover of: 32.00 vs. RWIHX (27.00). RWIHX has a lower initial minimum investment than RGGYX: RWIHX (250) vs RGGYX (1000000). RGGYX annual gain was more profitable for investors over the last year : 5.20 vs. RWIHX (1.64). RGGYX return over 5 years is better than : 83.85 vs. RWIHX (52.09).
RGGYXRWIHXRGGYX / RWIHX
Total Expense Ratio0.600.56107%
Annual Report Gross Expense Ratio0.840.56150%
Fund Existence14 years9 years-
Gain YTD-7.096-0.3132,266%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.25B119B1%
Annual Yield % from dividends1.221.8467%
Returns for 1 year5.201.64316%
Returns for 3 years29.3819.07154%
Returns for 5 years83.8552.09161%
Returns for 10 years98.14N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DUO0.260.03
+11.91%
Fangdd Network Group Ltd
LCTX0.500.03
+5.57%
Lineage Cell Therapeutics
SNDL1.480.06
+4.23%
SNDL
ASND160.452.31
+1.46%
Ascendis Pharma A/S
PRK148.780.87
+0.59%
Park National Corp